Skip to main content
. 2019 May 9;20(9):2296. doi: 10.3390/ijms20092296

Figure 3.

Figure 3

Aberrant expression of different kinases inhibits apoptosis and MHC-I expression and promotes PD-L1 overexpression, which leads to tumor cell enhanced survival and T-Cell inactivation or loss of recognition.